Necrobiotic xanthogranuloma, a rare complication of a persistently high paraprotein
Peripheral blood alterations in a patient with infectious mononucleosis
The role of haematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosis
Development of romiplostim for the treatment of patients with chronic immune thrombocytopenia: from bench to bedside
Peripheral T-cell lymphoma gene expression profiling and potential therapeutic exploitations
Monoclonal gammopathy of undetermined significance: a consensus statement
Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapy
AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders
Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1–2 study
A phase I study of vorinostat in combination with idarubicin in relapsed or refractory leukaemia
Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations
Purification of FANCD2 sub-complexes
Glucocerebrosidase deficiency dramatically impairs human bone marrow haematopoiesis in an in vitro model of Gaucher disease
NT-proBNP as a marker of cardiopulmonary status in sickle cell anaemia in Africa
Isoform-selective phosphoinositide 3-kinase inhibitors induce apoptosis in chronic lymphocytic leukaemia cells
Monocytes/macrophages but not T lymphocytes are the major targets of the CCL3/CCL4 chemokines produced by CD38+CD49d+ chronic lymphocytic leukaemia cells
Hairy cell leukaemia-variant and splenic red pulp lymphoma: a single entity?
HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy
Diagnosis of severe Type 1 Gaucher's disease before irreversible damage occurs : is HDL cholesterol the answer?
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study
A dodecapeptide deduced from cytokeratin sequence strongly enhances uPA/tPA-mediated plasminogen activation
Artificial contact pathway activation masks the haemostatic potential of rFVIIa and NN1731 in thrombocytopenic whole blood